C141H132N34O8S2 — CID 158039546
2-[4-(2-aminopyrimidin-5-yl)phenyl]-2,3-dimethyl-N-pyridin-4-ylbutanamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]cyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-pyridin-4-ylcyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-pyridin-3-yl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-pyridin-4-yl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;N-[5-(5-methoxy-3-pyridinyl)-2-pyridinyl]-4-[4-(1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl]oxane-4-carboxamide (PubChem CID 158039546) has the molecular formula C141H132N34O8S2 and a molecular weight of 2494.97 g/mol. Its IUPAC name is 2-[4-(2-aminopyrimidin-5-yl)phenyl]-2,3-dimethyl-N-pyridin-4-ylbutanamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]cyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-pyridin-4-ylcyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-pyridin-3-yl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-pyridin-4-yl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;N-[5-(5-methoxy-3-pyridinyl)-2-pyridinyl]-4-[4-(1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl]oxane-4-carboxamide.
| Compound Name | 2-[4-(2-aminopyrimidin-5-yl)phenyl]-2,3-dimethyl-N-pyridin-4-ylbutanamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]cyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-pyridin-4-ylcyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-pyridin-3-yl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-pyridin-4-yl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;N-[5-(5-methoxy-3-pyridinyl)-2-pyridinyl]-4-[4-(1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl]oxane-4-carboxamide |
|---|---|
| PubChem CID | 158039546 |
| Molecular Formula | C141H132N34O8S2 |
| Molecular Weight | 2494.97 g/mol |
| Exact Mass | 2493.04 |
| IUPAC Name | 2-[4-(2-aminopyrimidin-5-yl)phenyl]-2,3-dimethyl-N-pyridin-4-ylbutanamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]cyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-pyridin-4-ylcyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-pyridin-3-yl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-pyridin-4-yl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;N-[5-(5-methoxy-3-pyridinyl)-2-pyridinyl]-4-[4-(1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl]oxane-4-carboxamide |
| SMILES | CC(C)C(C)(C(=O)Nc1ccncc1)c1ccc(-c2cnc(N)nc2)cc1.COc1cncc(-c2ccc(NC(=O)C3(c4ccc(-c5cnc6[nH]ccc6c5)cc4)CCOCC3)nc2)c1.Cn1cc(-c2ccc(NC(=O)C3(c4ccc(-c5cnc(N)nc5)cc4)CCC3)nc2)cn1.Nc1ncc(-c2ccc(C3(C(=O)Nc4ccncc4)CCC3)cc2)cn1.Nc1ncc(-c2ccc(C3(C(=O)Nc4nc(-c5cccnc5)cs4)CCC3)cc2)cn1.Nc1ncc(-c2ccc(C3(C(=O)Nc4nc(-c5ccncc5)cs4)CCC3)cc2)cn1 |
| InChI | InChI=1S/C30H27N5O3.C24H23N7O.2C23H20N6OS.C21H23N5O.C20H19N5O/c1-37-26-15-24(16-31-19-26)22-4-7-27(33-17-22)35-29(36)30(9-12-38-13-10-30)25-5-2-20(3-6-25)23-14-21-8-11-32-28(21)34-18-23;1-31-15-19(14-29-31)17-5-8-21(26-11-17)30-22(32)24(9-2-10-24)20-6-3-16(4-7-20)18-12-27-23(25)28-13-18;24-21-26-12-17(13-27-21)15-2-4-18(5-3-15)23(8-1-9-23)20(30)29-22-28-19(14-31-22)16-6-10-25-11-7-16;24-21-26-12-17(13-27-21)15-4-6-18(7-5-15)23(8-2-9-23)20(30)29-22-28-19(14-31-22)16-3-1-10-25-11-16;1-14(2)21(3,19(27)26-18-8-10-23-11-9-18)17-6-4-15(5-7-17)16-12-24-20(22)25-13-16;21-19-23-12-15(13-24-19)14-2-4-16(5-3-14)20(8-1-9-20)18(26)25-17-6-10-22-11-7-17/h2-8,11,14-19H,9-10,12-13H2,1H3,(H,32,34)(H,33,35,36);3-8,11-15H,2,9-10H2,1H3,(H2,25,27,28)(H,26,30,32);2-7,10-14H,1,8-9H2,(H2,24,26,27)(H,28,29,30);1,3-7,10-14H,2,8-9H2,(H2,24,26,27)(H,28,29,30);4-14H,1-3H3,(H2,22,24,25)(H,23,26,27);2-7,10-13H,1,8-9H2,(H2,21,23,24)(H,22,25,26) |
| InChIKey | FIEJINYRLZYHGP-UHFFFAOYSA-N |
| XLogP | 24.43 |
| TPSA | 614.57 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 37 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 185 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2494.97 |
| LogP ≤ 5 | 24.43 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 37 |